Results 141 to 150 of about 208,986 (273)

S-ICD Implantation in Secondary Prevention in a Young Patient With Recent Surgically Repaired Pectus Excavatum

JACC: Case Reports
We report a case of successful implantation of a subcutaneous implantable cardioverter-defibrillator in a young patient with severe pectus excavatum presenting with out-of-hospital ventricular fibrillation arrest who was recently surgically repaired with
Luca Checchi, MD, Laura Perrotta, MD, PhD, Giuseppe Ricciardi, MD, PhD, Andrea Colella, MD, Gabriele Bambagioni, MD, Davide Ciliberti, MD, Valentina Bogini, MD, Alessandro Gonfiotti, MD, Iacopo Olivotto, MD, Paolo Pieragnoli, MD, PhD   +9 more
doaj  

Electrophysiological Substrate in Patients with Barlow’s Disease

Arrhythmia & Electrophysiology Review, 2021
Pasquale Vergara, Savino Altizio, Giulio Falasconi, Luigi Pannone, Simone Gulletta, Paolo Della Bella   +5 more
doaj   +1 more source

The relevance of β‐receptor blockade to ouabain‐induced cardiac arrhythmias [PDF]

, 1969
A N Dohadwalla, A. STONE FREEDBERG, E. M. Vaughan Williams   +2 more
openalex   +1 more source

Clinical profile, short and long‐term outcomes of non‐ischaemic cardiogenic shock: A FRENSHOCK sub‐analysis

ESC Heart Failure, EarlyView.
Abstract Aims Although predominant in routine practice, non‐ischaemic cardiogenic shock (NICS) remains underrepresented in past studies, mainly focused on ischaemic cardiogenic shock (CS). This study aims to describe the current NICS picture and define its independent correlates of short‐ and long‐term outcomes.
Miloud Cherbi, François Roubille, Edouard Gerbaud, Eric Bonnefoy, Nicolas Lamblin, Laurent Bonello, Bruno Levy, Pascal Lim, Hamid Merdji, Meyer Elbaz, Hadi Khachab, Jeremy Bourenne, Marie‐France Seronde, Guillaume Schurtz, Brahim Harbaoui, Gerald Vanzetto, Nicolas Combaret, Benoit Lattuca, Guillaume Leurent, Etienne Puymirat, Clément Delmas   +20 more
wiley   +1 more source

Cardiac Arrhythmias Induced by Minimal Doses of Epinephrine in Cyclopropane-Anesthetized Dogs [PDF]

, 1960
PETER B. DRESEL, Keith L. MacCannell, Mark Nickerson   +2 more
openalex   +1 more source

Long‐term outcomes of electrical storm patients listed for urgent heart transplantation but not transplanted acutely

ESC Heart Failure, EarlyView.
Abstract Aims Refractory electrical storm (ES) is a life‐threatening condition in which heart transplantation (HTx) can be proposed. Nevertheless, the shortage of donors and subsequent outcomes question its place as a rescue strategy. We aim to describe the prognosis of ES patients listed for HTx but not transplanted.
Miloud Cherbi, Philippe Maury, Léa Benabou, Maxime Faure, Matteo Pozzi, Laurent Sebbag, Estelle Gandjbakhch, Karim Benali, Pierre Groussin, Redwane Rakza, Raphael P. Martins, Clément Delmas   +11 more
wiley   +1 more source

Studies on the strophanthin arrhythmia

, 1954
Toshikazu Fujisawa
openalex   +2 more sources

Incidence of Arrhythmias in the Dog Following Transthoracic Ventricular Defibrillation with Unidirectional Rectangular Stimuli [PDF]

, 1968
Harry Stoeckle, S. H. Nellis, John C. Schuder   +2 more
openalex   +1 more source

Duration of sodium zirconium cyclosilicate treatment and continuation of RAASi therapy after a hyperkalaemia episode

ESC Heart Failure, EarlyView.
Abstract Aims Renin–angiotensin–aldosterone system inhibitors (RAASi) are foundational in the management of heart failure (HF) and chronic kidney disease (CKD) but increase the risk of hyperkalaemia. To facilitate continuation of RAASi therapy, guidelines suggest managing hyperkalaemia using newer potassium binders such as sodium zirconium ...
Charles V. Pollack Jr., David Arroyo, Eiichiro Kanda, Ignacio José Sánchez Lázaro, Eva Lesén, Stefan Franzén, Christen M. Gray, Anna Lipińska, Toyoaki Murohara, Anjay Rastogi   +9 more
wiley   +1 more source

Trametinib alters contractility of paediatric Noonan syndrome‐associated hypertrophic myocardial tissue slices

ESC Heart Failure, EarlyView.
Abstract Aims No curative treatment is available for RASopathy‐associated childhood‐onset hypertrophic cardiomyopathy (RAS‐CM). Preclinical data and individual reports suggest a beneficial effect of small molecules targeting the RAS–mitogen‐activated protein (MAP) kinase (MAPK) pathway in severely affected RAS‐CM patients.
Jules Hamers, Payel Sen, Sarala Raj Murthi, Laura Papanakli, Maria von Stumm, Francesca Baessato, Julie Cleuziou, Christian Meierhofer, Peter Ewert, Andreas Dendorfer, Daphne Merkus, Cordula M. Wolf   +11 more
wiley   +1 more source